Rick Pauls
Board Member
DiaMedica Therapeutics Inc. (DMAC)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | DiaMedica Therapeutics Inc. (DMAC) | President and Chief Executive Officer | $645,000 | $2,727,350 |
| 2024 | DiaMedica Therapeutics Inc. (DMAC) | President and Chief Executive Officer | $593,250 | $1,550,985 |
| 2023 | DiaMedica Therapeutics Inc. (DMAC) | President and Chief Executive Officer | $562,000 | $1,215,161 |
| 2022 | DiaMedica Therapeutics Inc. (DMAC) | President and Chief Executive Officer | $522,796 | $1,080,607 |
| 2021 | DiaMedica Therapeutics Inc. (DMAC) | President and Chief Executive Officer | $477,448 | $1,136,169 |
| 2020 | DiaMedica Therapeutics Inc. (DMAC) | President and Chief Executive Officer | $455,013 | $878,203 |
| 2019 | DiaMedica Therapeutics Inc. (DMAC) | President and Chief Executive Officer | $420,000 | $733,707 |
| 2018 | DiaMedica Therapeutics Inc. (DMAC) | President and Chief Executive Officer | $315,208 | $733,707 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.